Search by Drug Name or NDC

NDC 61269-0634-30 Zyprexa 15 mg/1 Details

Zyprexa 15 mg/1

Zyprexa is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by H2-Pharma LLC. The primary component is OLANZAPINE.

MedlinePlus Drug Summary

Olanzapine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and teenagers 13 years of age and older. It is also used to treat bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods) in adults and teenagers 13 years of age and older. Olanzapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Related Packages: 61269-0634-30
Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Olanzapine

Product Information

NDC	61269-0634
Product ID	61269-634_0862bfd3-af21-4d39-b301-15300f571a14
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Zyprexa
Proprietary Name Suffix	n/a
Non-Proprietary Name	Olanzapine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	15
Active Ingredient Units	mg/1
Substance Name	OLANZAPINE
Labeler Name	H2-Pharma LLC
Pharmaceutical Class	Atypical Antipsychotic [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA020592
Listing Certified Through	2024-12-31

Package

NDC 61269-0634-30 (61269063430)

Pricing Information	N/A
NDC Package Code	61269-634-30
Billing NDC	61269063430
Package	30 TABLET in 1 BOTTLE (61269-634-30)
Marketing Start Date	2000-01-10
NDC Exclude Flag	N